Power Point: Focus on the company’s mission

“I worry when people ask, ‘How many stock options am I going to get?’ We hire people who want to cure diseases.”

–Art Levinson, chairman and CEO of Genentech , said this during Genentech’s investor day in New York City this past March. Yesterday Levinson raised Genentech’s earnings forecast, and the stock is up substantially in a down market.